Citations

Showing 10 of 108083 citations.

A Comparison of Facial Protection and the Incidence of Head, Neck, and Facial Injuries in Junior a Hockey Players
Smith, Aynsley M., Malo-Ortiguera, Susan A., Fischer, Tracy L., Stuart, Michael J. , Larson, Dirk R.

Mayo Clinic

The American Journal of Sports Medicine | July 19, 2017 | Volume: 30 | Issue: 1 | Pages: 39-44

10.1177/03635465020300012001 | PMID 11798994 Get It

A cohort of 282 elite amateur ice hockey players were analyzed to 1) record the number, type, location, and severity of head, neck, and facial injuries sustained during games; 2) examine the relationship between injuries and the type of facial protection (none, partial, or full) according to individual playing time; and 3) determine whether full or partial facial protection is associated with an increased incidence of concussions, eye injuries, and neck injuries. Fifty-two injuries (158.9 per 1000 player-game hours) occurred in players wearing no facial protection, 45 (73.5 per 1000 player-game hours) in players wearing partial facial protection (half shield), and 16 (23.2 per 1000 player-game hours) in players wearing full facial protection (full cage or shield). Players wearing no protection were injured at a rate more than twice that of players wearing partial protection and almost seven times higher than those wearing full protection. Concussions occurred in four players wearing no protection, five players wearing partial protection, and two players wearing full protection; these differences were not significant. The risk of eye injury was 4.7 times greater for players wearing no protection compared with those wearing partial protection. No eye or neck injuries occurred in players wearing full protection. This study demonstrates that both full and partial facial protection significantly reduce injuries to the eye and face without increasing neck injuries and concussions.
Age-Related Changes in Normal Isometric Shoulder Strength
Johnson, Marjorie E., An, Kai‐Nan , Hughes, Richard E. , O’Driscoll, Shawn W.

Mayo Clinic

The American Journal of Sports Medicine | July 19, 2017 | Volume: 27 | Issue: 5 | Pages: 651-657

10.1177/03635465990270051801 | PMID 10496585 Get It

Normative data are useful for assessing isometric shoulder strength in patients with bilateral shoulder abnormalities. The purpose of this study was to develop a normative database for shoulder strength in the clinically relevant positions and movements. Twenty combinations of exertions and postures—including flexion, extension, abduction, adduction, internal rotation, and external rotation—were tested for both the dominant and nondominant sides. Strength was measured isometrically using a modified Cybex II dynamometer. The cross-sectional study design included 120 subjects (60 women and 60 men) ranging in age from 20 to 78 years from southern Minnesota. Tables of normative strength data were constructed. Multivariate analyses were performed to assess the effect of age, sex, and weight on strength. Age was negatively associated with all strength measures, and weight was positively associated with them. Men were stronger than women when controlling for age and weight. Statistically significant differences between dominant and nondominant shoulders were found for only some of the strength measures taken. These normal data will be useful to the clinician, as they permit a standard against which to compare shoulder strength.
The Effect of Foot Structure and Range of Motion on Musculoskeletal Overuse Injuries
Brodine, Stephanie K., Shaffer, Richard A., Johnson, Chrisanna Weech, Cullison, Thomas R., Kaufman, Kenton R.

Mayo Clinic

The American Journal of Sports Medicine | July 19, 2017 | Volume: 27 | Issue: 5 | Pages: 585-593

10.1177/03635465990270050701 | PMID 10496574 Get It

The purpose of this prospective study was to determine whether an association exists between foot structure and the development of musculoskeletal overuse injuries. The study group was a well-defined cohort of 449 trainees at the Naval Special Warfare Training Center in Coronado, California. Before beginning training, measurements were made of ankle motion, subtalar motion, and the static (standing) and dynamic (walking) characteristics of the foot arch. The subjects were tracked prospectively for injuries throughout training. We identified risk factors that predispose people to lower extremity overuse injuries. These risk factors include dynamic pes planus, pes cavus, restricted ankle dorsiflexion, and increased hindfoot inversion, all of which are subject to intervention and possible correction.
Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1–MAPK Interaction
Jin, Xin , Pan, Yunqian , Wang, Liguo , Zhang, Lizhi , Tang, Amy , Billadeau, Daniel D. , Wu, Heshui , Ma, Tao , Huang, Haojie , Wang, Liguo , Tang, Amy H , Jin, Xin

Mayo Clinic

Cancer Research | July 18, 2017 | Volume: 77 | Issue: 16 | Pages: 4328-4341

10.1158/0008-5472.can-16-3143 | PMID 28720574 Get It

Abstract Dysregulation of the MAPK pathway correlates with progression of pancreatic ductal adenocarcinoma (PDAC) progression. IQ motif containing GTPase-activating protein 1 (IQGAP1) is a MAPK scaffold that directly regulates the activation of RAF, MEK, and ERK. Fructose-1,6-bisphosphatase (FBP1), a key enzyme in gluconeogenesis, is transcriptionally downregulated in various cancers, including PDAC. Here, we demonstrate that FBP1 acts as a negative modulator of the IQGAP1–MAPK signaling axis in PDAC cells. FBP1 binding to the WW domain of IQGAP1 impeded IQGAP1-dependent ERK1/2 phosphorylation (pERK1/2) in a manner independent of FBP1 enzymatic activity. Conversely, decreased FBP1 expression induced pERK1/2 levels in PDAC cell lines and correlated with increased pERK1/2 levels in patient specimens. Treatment with gemcitabine caused undesirable activation of ERK1/2 in PDAC cells, but cotreatment with the FBP1-derived small peptide inhibitor FBP1 E4 overcame gemcitabine-induced ERK activation, thereby increasing the anticancer efficacy of gemcitabine in PDAC. These findings identify a primary mechanism of resistance of PDAC to standard therapy and suggest that the FBP1–IQGAP1–ERK1/2 signaling axis can be targeted for effective treatment of PDAC. Cancer Res; 77(16); 4328–41. ©2017 AACR.
Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia
Yan, Fei , Pang, Jiuxia, Zhao, Na , Gangat, Naseema , Bode, Ann M. , Al‐Kali, Aref , Litzow, Mark R. , Liu, Shujun , Shen, Na , Wu, Lai‐Chu

Mayo Clinic

Clinical Cancer Research | July 18, 2017 | Volume: 23 | Issue: 20 | Pages: 6254-6266

10.1158/1078-0432.ccr-17-0235 | PMID 28720666 Get It

Abstract Purpose: Receptor tyrosine kinases (RTKs) are frequently deregulated in leukemia, yet the biological consequences of this deregulation remain elusive. The mechanisms underlying aberrant methylation, a hallmark of leukemia, are not fully understood. Here we investigated the role of RTKs in methylation abnormalities and characterized the hypomethylating activities of RTK inhibitors. Experimental Design: Whether and how RTKs regulate expression of DNA methyltransferases (DNMTs), tumor suppressor genes (TSGs) as well as global and gene-specific DNA methylation were examined. The pharmacologic activities and mechanisms of actions of RTK inhibitors in vitro, ex vivo, in mice, and in nilotinib-treated leukemia patients were determined. Results: Upregulation of RTKs paralleled DNMT overexpression in leukemia cell lines and patient blasts. Knockdown of RTKs disrupted, whereas enforced expression increased DNMT expression and DNA methylation. Treatment with the RTK inhibitor, nilotinib, resulted in a reduction of Sp1-dependent DNMT1 expression, the diminution of global DNA methylation, and the upregulation of the p15INK4B gene through promoter hypomethylation in AML cell lines and patient blasts. This led to disruption of AML cell clonogenicity and promotion of cellular apoptosis without obvious changes in cell cycle. Importantly, nilotinib administration in mice and human patients with AML impaired expression of DNMTs followed by DNA hypomethylation, TSG re-expression, and leukemia regression. Conclusions: Our findings demonstrate RTKs as novel regulators of DNMT-dependent DNA methylation and define DNA methylation status in AML cells as a pharmacodynamic marker for their response to RTK-based therapy, providing new therapeutic avenues for RTK inhibitors in overcoming epigenetic abnormalities in leukemia. Clin Cancer Res; 23(20); 6254–66. ©2017 AACR.
Intrinsically disordered chromatin protein NUPR1 binds to the C-terminal region of Polycomb RING1B
Santofimia‐Castaño, Patricia , Rizzuti, Bruno , Pey, Ángel L. , Soubeyran, Philippe , Vidal, Miguel , Neira, José L. , Urrutia, Raúl , Iovanna, Juan , Santofimia-Castaño, Patricia

Mayo Clinic

Proceedings of the National Academy of Sciences | July 18, 2017 | Volume: 114 | Issue: 31 | Pages: No page available

10.1073/pnas.1619932114 | PMID 28720707 Get It

Significance We describe the interaction between an intrinsically disordered protein (IDP), NUPR1, and the well-folded C-terminal region of RING1B protein of the Polycomb complex, involving residues Ala33 and Thr68 of the IDP. These observations are significant because they raise the possibility that NUPR1 aids the function of the members of the Polycomb complex, playing an active role in carcinogenesis.
Advances in Collaborative Care
Williams, Mark D. , Katzelnick, David J.

Mayo Clinic

Focus | July 18, 2017 | Volume: 15 | Issue: 3 | Pages: 243-243

10.1176/appi.focus.20170025 | PMID 31975853 Get It

Systematic Case Review in Integrated Care
Katzelnick, David J.

Mayo Clinic

Focus | July 18, 2017 | Volume: 15 | Issue: 3 | Pages: 292-293

10.1176/appi.focus.20170019 | PMID 31975860 Get It

The Role of Integrated Care in Managing Chronic Pain
Leasure, William B. , Leasure, Emily L.

Mayo Clinic

Focus | July 18, 2017 | Volume: 15 | Issue: 3 | Pages: 284-291

10.1176/appi.focus.20170014 | PMID 31975859 Get It